VCM
IMGN

Versant Capital Management’s Immunogen Inc IMGN Stock Holding History

Versant Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37
Closed -$698 – 2092
2023
Q2 		$698 Buy
+37
New +$437 ﹤0.01% 1728
2019
Q4 		– Sell
-1,404
Closed -$3K – 1643
2019
Q3 		$3K Buy
+1,404
New +$3.73K ﹤0.01% 1123
2019
Q2 		– Sell
-51
Closed – – 1775
2019
Q1 		$0 Buy
+51
New +$221 ﹤0.01% 1781

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Versant Capital Management's IMGN Position: Q3 2023 in Review

Versant Capital Management sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 37 shares — an estimated $698 sold.

Versant Capital Management first reported a position in IMGN in Q1 2019 and held it in 3 quarters. The position peaked at $3K in Q3 2019. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • Versant Capital Management reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • Versant Capital Management sold 37 Immunogen Inc shares in Q3 2023, an estimated $698.
  • Versant Capital Management first reported a position in Immunogen Inc in Q1 2019 and held it in 3 quarters.
  • Versant Capital Management's Immunogen Inc position peaked at $3K in Q3 2019.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Versant Capital Management's 13F filing for Q3 2023, filed 12 Oct 2023.